Longview Acquisition Corp. II (LGV) to Combine with HeartFlow in $2.4Bn Deal

Jul 15, 2021 INTEL by Nicholas Alan Clayton

Longview II (NYSE:LGV) has entered into a definitive agreement to combine with medtech firm HeartFlow at an enterprise value of $2.37 billion, or 11.6x its 2023E revenue. Redwood City, California-based HeartFlow provides tools for visualizing blood circulation around the heart, giving physicians insights into further treatment options. The combined company will trade on the NYSE
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Longview Acquisition Corp. II (LGV) to Combine with HeartFlow in $2.4Bn Deal

Longview Acquisition Corp. II (LGV) to Combine with HeartFlow in $2.4Bn Deal

ByNicholas Alan Clayton